It is rapidly upregulated in response to renal damage and has shown great promise as an early diagnostic biomarker in the context of AKI.11 Beyond its role in renal injury, emerging evidence suggests that NGAL may also be involved in various other pathological conditions, including cardiovascular diseases. This evidence concerns the gene LCN2 and acute kidney injury.